China’s National Small & Medium Enterprises Development Fund has led a RMB130 million ($18 million) Series A round for Tianyancha, a Beijing-based business data search firm.
Alibaba Group has taken full ownership of Damai.cn, a leading Chinese online ticketing platform that previously raised funding from VC investors.
Eight Roads decided to leverage the development of China’s healthcare sector by building a hospital, but addressing the various challenges that come with a greenfield strategy requires very patient capital
Gaining an accurate impression of an industry is vital for investors, but this can be difficult in markets where information is patchy or unreliable. Those who hope to prosper must learn to judge data carefully
China-focused GPs CMC Capital Partners and HG Capital have jointly led a RMB180 million ($26 million) Series B round of funding for Newrank, a Shanghai-based media platform.
Chinese outbound online travel platforms Woqu.com and Lulutrip – both of which have received several rounds of funding from VC and strategic investors – have agreed to merge. The combined entity has received $25 million in new funding.
PAG Asia Capital has led a $100 million Series C round of funding for Mychebao.com, a Chinese online auction platform for second-hand cars.
Suzhou Ribo Life Science, a Chinese drug developer that focuses on liver diseases, has raised a RMB270 million ($40 million) Series B round led by SDIC Fund Management.
Chinese logistics and warehousing robotics developer Geek+ has raised a RMB100 million ($14 million) round of funding led by Vertex Ventures China.
Kuo-Chan Kung, former head of Greater China at MBK Partners (pictured), is launching his own private equity firm called Nexus Point Partners.
Evolution Media China (EMC) and Shenzhen Capital Group have led a $30 million Series B round for Shenzhen-based education and robotics start-up Makeblock.
Guangzhou Industrial Investment Fund Management, an investment arm of the Guangzhou government, has partnered with China Reform Holdings and Shanghai Pudong Development Bank to launch a state-owned enterprise (SOE) restructuring fund with a target size...
The credit and distress investment opportunity is significant – and expected to grow – but an on-the-ground presence is seen as essential to accessing it, industry participants told the AVCJ China Forum.
Chinese GPs are shifting to buyout strategies with a view to having more influence and operational input in portfolio companies, but they should have clear plans on post-deal integration when making these investments.
China is adjusting to a slower growth model driven by consumption rather than investment, but significant gains can still be made through productivity and innovation, industry participants told the AVCJ China Forum.
US payment services company Euronet Worldwide has extended a buyout offer worth about $2 billion for NASDAQ-listed MoneyGram, contesting a bid made earlier this year by Alibaba Group’s PE-backed affiliate Ant Financial. The pending sale will provide...
China agriculture investor Hosen Capital has completed its evolution from a corporate-sponsored GP into an independent player with a $440 million fundraise from institutional and industrial LPs
Chinese VC firms are expected to offer value-added services as a way of differentiating themselves from the competition. Are formalized concierge services for founders and their families a step too far?
The emergence of internet-connected manufacturing has created a new investment area that will impact adjacent sectors and even entire economies for decades to come. PE is among the early movers
Lorna Chen, partner and head of the Asia asset management and investment funds practice at Shearman & Sterling, discusses China outbound investment
CMC Holdings – a unit of media-focused GP CMC Capital Partners – and Sequoia Capital China have formed a sports investment fund and led a Series A round of funding for Wanmingyang Media, which organizes and video streams kickboxing events in China.
Healthcare-focused PE investor Ally Bridge Group will support the HK$2.3 billion ($301 million) management-led take-private of Hong Kong-listed Shandong Luoxin Pharmacy Group.